These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21147921)

  • 41. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice.
    Reinert LS; Harder L; Holm CK; Iversen MB; Horan KA; Dagnæs-Hansen F; Ulhøi BP; Holm TH; Mogensen TH; Owens T; Nyengaard JR; Thomsen AR; Paludan SR
    J Clin Invest; 2012 Apr; 122(4):1368-76. PubMed ID: 22426207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of polymorphonuclear leukocytes in resolution of HSV-2 infection of the mouse vagina.
    Milligan GN; Bourne N; Dudley KL
    J Reprod Immunol; 2001 Jan; 49(1):49-65. PubMed ID: 11137112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI; Bourne N
    J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-36γ Is a Key Regulator of Neutrophil Infiltration in the Vaginal Microenvironment and Limits Neuroinvasion in Genital HSV-2 Infection.
    Gardner JK; Swaims-Kohlmeier A; Herbst-Kralovetz MM
    J Immunol; 2019 Nov; 203(10):2655-2664. PubMed ID: 31578266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin.
    Royer DJ; Carr DJ
    Mucosal Immunol; 2016 Jul; 9(4):1065-75. PubMed ID: 26627457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2.
    Parr EL; Parr MB
    Immunology; 1999 Dec; 98(4):639-45. PubMed ID: 10594699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute Infection and Subsequent Subclinical Reactivation of Herpes Simplex Virus 2 after Vaginal Inoculation of Rhesus Macaques.
    Lo M; Zhu J; Hansen SG; Carroll T; Farr Zuend C; Nöel-Romas L; Ma ZM; Fritts L; Huang ML; Sun S; Huang Y; Koelle DM; Picker LJ; Burgener A; Corey L; Miller CJ
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30333177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.
    Halford WP; Geltz J; Messer RJ; Hasenkrug KJ
    PLoS One; 2015; 10(12):e0145228. PubMed ID: 26670699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon.
    Bird MD; Chu CF; Johnson AJ; Milligan GN
    J Virol; 2007 Jan; 81(1):423-6. PubMed ID: 17065206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1.
    Quispe Calla NE; Vicetti Miguel RD; Torres AR; Trout W; Gabriel JM; Hatfield AM; Aceves KM; Kwiek JJ; Kaur B; Cherpes TL
    Immunohorizons; 2020 Feb; 4(2):72-81. PubMed ID: 32047094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Depot-medroxyprogesterone acetate reduces genital cell-cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion.
    Quispe Calla NE; Vicetti Miguel RD; Aceves KM; Torres A; Cherpes TL
    Contraception; 2019 Nov; 100(5):397-401. PubMed ID: 31302121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fas/FasL pathway participates in resolution of mucosal inflammatory response early during HSV-2 infection.
    Krzyzowska M; Baska P; Grochowska A; Orlowski P; Nowak Z; Winnicka A
    Immunobiology; 2014 Jan; 219(1):64-77. PubMed ID: 24028839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
    Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
    PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychological stress exacerbates primary vaginal herpes simplex virus type 1 (HSV-1) infection by impairing both innate and adaptive immune responses.
    Ashcraft KA; Bonneau RH
    Brain Behav Immun; 2008 Nov; 22(8):1231-40. PubMed ID: 18639627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gammadelta T cell response induced by vaginal Herpes simplex 2 infection.
    Rakasz E; Mueller A; Perlman S; Lynch RG
    Immunol Lett; 1999 Nov; 70(2):89-93. PubMed ID: 10569697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
    Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NK cells require type I IFN receptor for antiviral responses during genital HSV-2 infection.
    Gill N; Chenoweth MJ; Verdu EF; Ashkar AA
    Cell Immunol; 2011; 269(1):29-37. PubMed ID: 21477795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraepithelial gammadelta T cells may bridge a gap between innate immunity and acquired immunity to herpes simplex virus type 2.
    Nishimura H; Yajima T; Kagimoto Y; Ohata M; Watase T; Kishihara K; Goshima F; Nishiyama Y; Yoshikai Y
    J Virol; 2004 May; 78(9):4927-30. PubMed ID: 15078977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections.
    Whaley KJ; Zeitlin L; Barratt RA; Hoen TE; Cone RA
    J Infect Dis; 1994 Mar; 169(3):647-9. PubMed ID: 8158042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.